825 related articles for article (PubMed ID: 24413974)
1. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
2. Trigger factor assisted self-assembly of canine parvovirus VP2 protein into virus-like particles in Escherichia coli with high immunogenicity.
Nan L; Liu Y; Ji P; Feng H; Chen C; Wang J; Liu D; Cui Y; Wang Y; Li Y; Zhou E; Zhang G
Virol J; 2018 Jun; 15(1):103. PubMed ID: 29921294
[TBL] [Abstract][Full Text] [Related]
3. An oral Sindbis virus replicon-based DNA vaccine containing VP2 gene of canine parvovirus delivered by Escherichia coli elicits immune responses in dogs.
Dahiya SS; Saini M; Kumar P; Gupta PK
Acta Virol; 2011; 55(4):289-94. PubMed ID: 22149493
[TBL] [Abstract][Full Text] [Related]
4. [Effects of canine IL-2 and IL-7 genes on enhancing immunogenicity of canine parvovirus VP2 gene vaccine in mice].
Chen H; Zhong F; Li X; Wang L; Sun Y; Neng C; Zhang K; Li W; Wen J
Wei Sheng Wu Xue Bao; 2012 Nov; 52(11):1392-9. PubMed ID: 23383511
[TBL] [Abstract][Full Text] [Related]
5. Administration with Vaccinia Virus Encoding Canine Parvovirus 2
Zhao W; Wang X; Li Y; Li Y
Viral Immunol; 2020; 33(6):434-443. PubMed ID: 32364832
[TBL] [Abstract][Full Text] [Related]
6. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
[TBL] [Abstract][Full Text] [Related]
7. [Escherichia coli heat-labile enterotoxin B subunit enhances the immune response against canine parvovirus VP2 in mice immunized by VP2 DNA vaccine].
Han D; Zhong F; Li X; Wang W; Wang X; Pan S
Wei Sheng Wu Xue Bao; 2011 Jan; 51(1):91-7. PubMed ID: 21465794
[TBL] [Abstract][Full Text] [Related]
8. Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper.
Chandran D; Shahana PV; Rani GS; Sugumar P; Shankar CR; Srinivasan VA
Vaccine; 2009 Dec; 28(1):132-9. PubMed ID: 19818723
[TBL] [Abstract][Full Text] [Related]
9. Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure.
Mittal M; Chakravarti S; Mohapatra JK; Chug PK; Dubey R; Upmanuyu V; Narwal PS; Kumar A; Churamani CP; Kanwar NS
Infect Genet Evol; 2014 Apr; 23():1-6. PubMed ID: 24486948
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
[TBL] [Abstract][Full Text] [Related]
11. High-yield production of canine parvovirus virus-like particles in a baculovirus expression system.
Jin H; Xia X; Liu B; Fu Y; Chen X; Wang H; Xia Z
Arch Virol; 2016 Mar; 161(3):705-10. PubMed ID: 26666439
[TBL] [Abstract][Full Text] [Related]
12. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
[TBL] [Abstract][Full Text] [Related]
13. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
Siedek EM; Schmidt H; Sture GH; Raue R
Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
[TBL] [Abstract][Full Text] [Related]
15. Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus.
Langeveld JP; Brennan FR; Martínez-Torrecuadrada JL; Jones TD; Boshuizen RS; Vela C; Casal JI; Kamstrup S; Dalsgaard K; Meloen RH; Bendig MM; Hamilton WD
Vaccine; 2001 Jun; 19(27):3661-70. PubMed ID: 11395200
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Chicken IgY Generated Against Canine Parvovirus Viral-Like Particles and Development of Enzyme-Linked Immunosorbent Assay and Immunochromatographic Assay for Canine Parvovirus Detection.
He J; Wang Y; Sun S; Zhang X
Viral Immunol; 2015 Nov; 28(9):489-94. PubMed ID: 26469376
[TBL] [Abstract][Full Text] [Related]
18. Immunodetection of Canine Parvovirus (CPV) in clinical samples by polyclonal antisera against CPV-VP2 protein expressed in Esherichia coli as an antigen.
Park JS; Choi BK; Vijayachandran LS; Ayyappan V; Chong CK; Lee KS; Kim SC; Choi CW
J Virol Methods; 2007 Dec; 146(1-2):281-7. PubMed ID: 17825928
[TBL] [Abstract][Full Text] [Related]
19. No evidence for a role of modified live virus vaccines in the emergence of canine parvovirus.
Truyen U; Geissler K; Parrish CR; Hermanns W; Siegl G
J Gen Virol; 1998 May; 79 ( Pt 5)():1153-8. PubMed ID: 9603330
[TBL] [Abstract][Full Text] [Related]
20. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
Larson LJ; Schultz RD
Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
